{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:03:08Z","timestamp":1791219788756,"version":"4.1.0"},"reference-count":52,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,5,23]]},"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      To explore the prevalence of\n                      <jats:italic>Helicobacter pylori<\/jats:italic>\n                      infection in Japan and the trends of its eradication therapy before and after the changes of the insurance coverage policy, first started in 2000, and expanded to cover\n                      <jats:italic>H. pylori<\/jats:italic>\n                      -positive gastritis in 2013. The impacts that the changes brought were estimated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this retrospective observational study and simulation study based on health insurance claims data, product sales data and relevant studies, individuals who received triple therapy (amoxicillin, clarithromycin, proton-pump inhibitors or potassium-competitive acid blockers) were defined as the first-time patients for\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication in two Japanese health insurance claims databases (from approximately 1.6 million and 10.5 million individuals). Each sales data of eradication packages and examination kits were used to estimate the number of\n                      <jats:italic>H. pylori<\/jats:italic>\n                      -eradicated individuals nationwide. The prevalence of\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection, including the future rate, was predicted using previous studies and the estimated population trend by a national institute. Cases completed prior to the policy change on insurance coverage were simulated to estimate what would have happened had there been no change in the policy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The numbers of patients first received eradication therapy were 81 119 and 170 993 from two databases. The nationwide estimated number of patients successfully eradicated was approximately 650 000 per year between 2001 and 2012, whereas it rapidly rose to 1 380-000 per year in 2013. The estimated prevalence of infection in 2050 is 5%, this rate was estimated to be 28% and 22% if the policy changes had not occurred in 2000 and 2013, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The impact of policy changes for\n                      <jats:italic>H. pylori<\/jats:italic>\n                      eradication therapy on the prevalence of infection was shown. The results suggest that insurance coverage expansion may also reduce the prevalence in other countries with a high prevalence of\n                      <jats:italic>H. pylori<\/jats:italic>\n                      infection if the reinfection is low.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-015855","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T20:25:36Z","timestamp":1501532736000},"page":"e015855","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":66,"title":["Impact of health insurance coverage for\n                    <i>Helicobacter pylori<\/i>\n                    gastritis on the trends in eradication therapy in Japan: retrospective observational study and simulation study based on real-world data"],"prefix":"10.1136","volume":"7","author":[{"given":"Shinzo","family":"Hiroi","sequence":"first","affiliation":[{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan"},{"name":"Japan Medical Affairs, Takeda Pharmaceutical Company Limited, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sugano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,7,31]]},"reference":[{"key":"2025101810370611000_7.7.e015855.1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"2025101810370611000_7.7.e015855.2","unstructured":"World Cancer research Fund International. Stomach cancer statistics, 2016. http:\/\/www.wcrf.org\/int\/cancer-facts-figures\/data-specific-cancers\/stomach-cancer-statistics."},{"key":"2025101810370611000_7.7.e015855.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61159-9"},{"key":"2025101810370611000_7.7.e015855.4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5694\/j.1326-5377.1985.tb113443.x","article-title":"Attempt to fulfil Koch's postulates for pyloric Campylobacter","volume":"142","author":"Marshall","year":"1985","journal-title":"Med J Aust"},{"key":"2025101810370611000_7.7.e015855.5","first-page":"192","article-title":"Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH","volume":"82","author":"Morris","year":"1987","journal-title":"Am J Gastroenterol"},{"key":"2025101810370611000_7.7.e015855.6","unstructured":"IARC Working Group. Helicobacter pylori eradication as a strategy for preventing gastric Cancer, 2014. https:\/\/www.iarc.fr\/en\/publications\/pdfs-online\/wrk\/wrk8\/Helicobacter_pylori_Eradication.pdf."},{"key":"2025101810370611000_7.7.e015855.7","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12034"},{"key":"2025101810370611000_7.7.e015855.8","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i6.1493"},{"key":"2025101810370611000_7.7.e015855.9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s005350300061","article-title":"Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients","volume":"38","author":"Asaka","year":"2003","journal-title":"J Gastroenterol"},{"key":"2025101810370611000_7.7.e015855.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.3.812"},{"key":"2025101810370611000_7.7.e015855.11","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini","year":"1998","journal-title":"Lancet"},{"key":"2025101810370611000_7.7.e015855.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199302043280503"},{"key":"2025101810370611000_7.7.e015855.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.01109.x"},{"key":"2025101810370611000_7.7.e015855.14","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.101634"},{"key":"2025101810370611000_7.7.e015855.15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1083-4389.2004.00194.x"},{"key":"2025101810370611000_7.7.e015855.16","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.mcg.0000248006.80699.7f","article-title":"The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer","volume":"42","author":"Ogura","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"2025101810370611000_7.7.e015855.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.41384.x"},{"key":"2025101810370611000_7.7.e015855.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03268.x"},{"key":"2025101810370611000_7.7.e015855.19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.2.187"},{"key":"2025101810370611000_7.7.e015855.20","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91409-F"},{"key":"2025101810370611000_7.7.e015855.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2009.00738.x"},{"key":"2025101810370611000_7.7.e015855.22","first-page":"74","article-title":"Eradication therapy in the era of Helicobacter pylori infection -Its issues-: current status and issues of Helicobacter pylori treatment in Ichikikushikino-city (Kagoshima Prefecture)","volume":"18","author":"Hanamure","year":"2014","journal-title":"Helicobacter Research"},{"key":"2025101810370611000_7.7.e015855.23","first-page":"314","article-title":"The changes in Helicobacter pylori infection treatment: is the number of infection reduced?","volume":"18","author":"Fujimori","year":"2014","journal-title":"Helicobacter Research"},{"key":"2025101810370611000_7.7.e015855.24","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0897-8"},{"key":"2025101810370611000_7.7.e015855.25","doi-asserted-by":"publisher","DOI":"10.1159\/000357859"},{"key":"2025101810370611000_7.7.e015855.26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gtc.2015.05.010","article-title":"Helicobacter pylori\u00a0eradication to eliminate gastric cancer: the Japanese strategy","volume":"44","author":"Asaka","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"2025101810370611000_7.7.e015855.27","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/0016-5085(92)90156-S","article-title":"Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population","volume":"102","author":"Asaka","year":"1992","journal-title":"Gastroenterology"},{"key":"2025101810370611000_7.7.e015855.28","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0016-5085(97)80004-2","article-title":"How is Helicobacter pylori transmitted?","volume":"113","author":"Cave","year":"1997","journal-title":"Gastroenterology"},{"key":"2025101810370611000_7.7.e015855.29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00535-012-0536-9","article-title":"Reinfection rate of Helicobacter pylori after eradication treatment: a long-term prospective study in Japan","volume":"47","author":"Take","year":"2012","journal-title":"J Gastroenterol"},{"key":"2025101810370611000_7.7.e015855.30","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-5378.2003.00143.x"},{"key":"2025101810370611000_7.7.e015855.31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01283.x"},{"key":"2025101810370611000_7.7.e015855.32","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.055400"},{"key":"2025101810370611000_7.7.e015855.33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/hel.12110","article-title":"Prevalence of Helicobacter pylori infection by birth year and geographic area in Japan","volume":"19","author":"Ueda","year":"2014","journal-title":"Helicobacter"},{"key":"2025101810370611000_7.7.e015855.34","doi-asserted-by":"publisher","DOI":"10.1586\/egh.12.67"},{"key":"2025101810370611000_7.7.e015855.35","unstructured":"Ministry of Health, Labour and Welfare. Summary report of vital statistics of Japan 2013 final data, 2014. http:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/kakutei13\/index.html. Japanese."},{"key":"2025101810370611000_7.7.e015855.36","unstructured":"National Institute of Population and Social Security Research. [Future population prediction in Japan]. 2012 http:\/\/www.ipss.go.jp\/syoushika\/tohkei\/newest04\/sh2401top.html."},{"key":"2025101810370611000_7.7.e015855.37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2009.06188.x"},{"key":"2025101810370611000_7.7.e015855.38","doi-asserted-by":"publisher","DOI":"10.2188\/jea.7.251"},{"key":"2025101810370611000_7.7.e015855.39","first-page":"81","article-title":"Seroprevalence of Helicobacter pylori\u00a0infection in urban and rural Vietnam","volume":"12","author":"Hoang","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2025101810370611000_7.7.e015855.40","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12250"},{"key":"2025101810370611000_7.7.e015855.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.2007.00504.x"},{"key":"2025101810370611000_7.7.e015855.42","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-104"},{"key":"2025101810370611000_7.7.e015855.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.01.011"},{"key":"2025101810370611000_7.7.e015855.44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.5694\/mja16.00104","article-title":"Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection","volume":"204","author":"Mitchell","year":"2016","journal-title":"Med J Aust"},{"key":"2025101810370611000_7.7.e015855.45","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.08.018"},{"key":"2025101810370611000_7.7.e015855.46","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj018"},{"key":"2025101810370611000_7.7.e015855.47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2011.00874.x","article-title":"Epidemiology of Helicobacter pylori infection and public health implications","volume":"16 Suppl 1","author":"Goh","year":"2011","journal-title":"Helicobacter"},{"key":"2025101810370611000_7.7.e015855.48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01375.x"},{"key":"2025101810370611000_7.7.e015855.49","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.5.2246-2250.2005"},{"key":"2025101810370611000_7.7.e015855.50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1523-5378.2007.00510.x","article-title":"Helicobacter pylori colonization in the first 3 years of life in Japanese children","volume":"12","author":"Okuda","year":"2007","journal-title":"Helicobacter"},{"key":"2025101810370611000_7.7.e015855.51","unstructured":"The committee of the Japanese society for Helicobacter research. [Guidelines for diagnosis and treatment of H. pylori infection in Japan: 2016 revised edition. Tokyo: Sentan Igaku-Sha, 2016. Japanese."},{"key":"2025101810370611000_7.7.e015855.52","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311304"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-015855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:37:17Z","timestamp":1760809037000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-015855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,31]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/bmjopen-2017-015855"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-015855","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}